National Securities Corporation will host a discussion with VBI Vaccines' CEO Jeff Baxter, & Chief Scientific Officer Dave Anderson, PhD.
National Securities' Senior Biotechnology Analyst, Cosme Ordonez MD, PhD, will be hosting a discussion with the management team of VBI Vaccines to discuss the evolving COVID-19 vaccine landscape. With the global community largely "over the hump" from peak infection, the discussion will focus on current vaccine uptake, the development of variant targeting vaccines, the need for potential booster doses, preparation for the next coronavirus threat and other longer term strategies.
Please register below for event login details. We hope to see you there.